The estimated Net Worth of Andrew Xilas is at least 1.59 百万$ dollars as of 4 December 2023. Andrew Xilas owns over 333 units of Steris Plc stock worth over 1,590,092$ and over the last 3 years Andrew sold STE stock worth over 0$.
Andrew has made over 8 trades of the Steris Plc stock since 2021, according to the Form 4 filled with the SEC. Most recently Andrew exercised 333 units of STE stock worth 80,606$ on 4 December 2023.
The largest trade Andrew's ever made was exercising 607 units of Steris Plc stock on 7 October 2021 worth over 146,930$. On average, Andrew trades about 239 units every 49 days since 2021. As of 4 December 2023 Andrew still owns at least 6,569 units of Steris Plc stock.
You can see the complete history of Andrew Xilas stock trades at the bottom of the page.
Andrew's mailing address filed with the SEC is C/O 70 SIR JOHN ROGERSON'S QUAY, , DUBLIN, L2, 2.
Over the last 9 years, insiders at Steris Plc have traded over 157,726,045$ worth of Steris Plc stock. The most active insiders traders include Richard Martin Steeves、Walter M Jr Rosebrough、John P Wareham. On average, Steris Plc executives and independent directors trade stock every 19 days with the average trade being worth of 3,374,074$. The most recent stock trade was executed by Christopher S Holland on 8 August 2024, trading 473 units of STE stock currently worth 113,369$.
steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
Steris Plc executives and other stock owners filed with the SEC include: